Evaluation of parathyroid function and mineral metabolism in psychiatric patients using lithium salts;Avaliação da função paratireoidiana e metabolismo mineral em pacientes psiquiátricos usuários de sais de lítio

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 58, Issue 6, 2014, Pages 619-624

  de Oliveira, Thiago Costa ^a   De Campos Neto, Ivo Alves ^a   de Aguiar Oliveira, Manuel Hermínio ^a   Pereira, Francisco de Assis ^a  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

Hyperparathyroidism; Lithium; Mineral metabolism; Parathyroid

Indexed keywords

25-HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; CREATININE; LITHIUM DERIVATIVE; MINERAL; PARATHYROID HORMONE; PHOSPHORUS; SERUM ALBUMIN; UREA; VITAMIN D;

ADULT; AGED; ANALOGS AND DERIVATIVES; BIPOLAR DISORDER; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECTS; FEMALE; HUMAN; HYPERPARATHYROIDISM, SECONDARY; MALE; MENTAL DISORDERS; METABOLISM; MIDDLE AGED; PARATHYROID GLAND; PHYSIOLOGY;

ADULT; AGED; ALKALINE PHOSPHATASE; BIPOLAR DISORDER; CALCIUM; CASE-CONTROL STUDIES; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; LITHIUM COMPOUNDS; MALE; MENTAL DISORDERS; MIDDLE AGED; MINERALS; PARATHYROID GLANDS; PARATHYROID HORMONE; PHOSPHORUS; SERUM ALBUMIN; UREA; VITAMIN D;

EID: 84907013024     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/0004-2730000002983     Document Type: Article

References (39)

1. Saunders BD, Saunders EFH, Gauger PG. Lithium therapy and hyperparathyroidism: an evidence-based assessment. World J Surg. 2009; 33: 2314-23.
2. Price LH, Heninger GR. Lithium in the treatment of mood disorders. N Engl J Med. 1994;331(9):591-8.
3. Mcknight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379:721-8.
4. Rosa AR, Kapczinski F, Oliva R, Stein A, Barros HMT. Monitoramento da adesão ao tratamento com lítio. Rev Psiq Clín. 2006;33(5):249-61.
5. Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behaviour and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. 2005;162:1805-19.
6. Martin LNC, Kayath MJ. Abordagem clínico-laboratorial no diagnóstico diferencial de hipercalcemia. Arq Bras Endocrinol Metab. 1999;43(6):472-9.
7. Ministério da Saúde. Profissional e Gestor – Medicamentos-Relação Nacional de Medicamentos Essenciais (RENAME 2012). Avaliable at: http://www.saude.gov.br. Accessed on: Jul 3, 2013.
8. Rang HP, Dale MM, Ritter JM, Flower RJ. Rang & Dale Farmacologia. 6th. Rio de Janeiro: Elsevier. 2007;557-74.
9. Collins N, Barnes TR, Shingleton-Smith A, Garret D, Paton C. Standards of lithium monitoring in mental health trusts in the UK. BMC Psychiatry. 2010;10:80.
10. Giusti CF, Amorim SR, Guerra RA, Portes ES. Endocrine disturbances related to the use of lithium. Arq Bras Endocrinol Metab. 2012;56(3):153-8.
11. Mármol F. Litio: 55 años de historia en el tratamiento del trastorno bipolar. Med Clin (Barc). 2005;127(5):189-95.
12. Oliveira JL, Silva Júnior GB, Abreu KLS, Rocha NA, Franco LFLG, Araújo SMHA, et al. Nefrotoxicidade por lítio. Rev Assoc Med Bras. 2010;56(5):600-6.
13. Timmer RT, Sands JM. Lithium intoxication. J Am Soc Nephrol. 1999;10:666-74.
14. Bhuvaneswar CG, Baldessarini RJ, Harsh VL, Alpert JE. Adverse endocrine and metabolic effects of psychotropic drugs. CNS Drugs. 2009;23(12):1003-21.
15. Mak TWL, Shek C, Chow C, Wing Y, Lee S. Effects of lithium therapy on bone mineral metabolism: a two-year prospective longitudinal study. J Clin Endocrinol Metab. 1998;83(11):3857-9.
16. Marx SJ. Hyperparathyroid and hyperparathyroid disorders. N Engl J Med. 2000;343(25):1863-75.
17. Grüfeld JP, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol. 2009;5:270-6.
18. Hundley JC, Woodrum DT, Saunders BD, Doherty GM, Gauger PG. Revisiting lithium-associated hyperparathyroidism in the era of intraoperative parathyroid hormone monitoring. Surgery. 2005;138:1027-31.
19. Szalat A, Mazeh H, Freund HR. Lithium-associated hyperpara-thyroidism: report of four cases and review of the literature. Eur J Endocrinol. 2009;160(2):317-23.
20. Nair CG, Menon R, Jacob P, Babu M. Lithium-induced parathyroid dysfunction: A new case. Indian. J Endocrinol Metab. 2013;17(5):930-2.
21. Skandarajah AR, Palazzo FF, Henry JF. Lithium-associated hyper-parathyroidism: surgical strategies in the era of minimally invasive parathyroidectomy. World J Surg. 2011;35:2432-9.
22. Prospero JD, Baptista PPR, Amary MFC, Santos PPC. Paratireoides: estrutura, funções e patologia. Acta Ortop Bras. 2008;17(2):53-7.
23. Gómez JMC. Evaluación diagnóstica e diagnóstico diferencial del hiperparatiroidismo primário. Endocrinol Nutr. 2009;56(Supl 1):14-9.
24. Bilezikian JP, Silverberg SJ. Asymptomatic primary hyperpara-thyroidism. N Engl J Med. 2004;350(17):1746-51.
25. Marques TF, Vasconcelos R, Diniz E, Rêgo D, Griz L, Bandeira F. Normocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat? Arq Bras Endocrinol Metab. 2011;55(5):314-7.
26. Komatsu M, Shimizu H, Tsuruta T, Kato M, Fushimi T, Inoue K, et al. Effect of lithium on serum calcium level and parathyroid function in maniac-depressive patients. Endocr J. 1995;42:691-5.
27. Gregoor PS, Jong GM. Lithium hypercalcemia, hyperparathyroidism and cinacalcet. Kidney Int. 2007;71:470.
28. Kusalic M, Engelsmann F. Effect of lithium maintenance therapy on thyroid and parathyroid function. J Psychiatry Neurosci. 1999;24:227-33.
29. Haden ST, Stoll AL, Mccormick S, Scott J, Fuleihan GE. Alterations in parathyroid dynamics in lithium-treated subjects. J Clin Endocrinol Metab. 1997;82:2844-8.
30. Carchman E, Ogilvie J, Holst J, Yim J, Carty S. Appropriate surgical treatment of lithium-associated hyperparathyroidism. World J Surg. 2008;32:2195-9.
31. Awad SS, Miskulin H, Thompson N. Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperpara-thyroidism in patients with prolonged lithium therapy. World J Surg. 2003;27:486-8.
32. Adegboyega PA, Okorodudu AO. Intracellular ionized calcium and increasing doses of lithium chloride therapy in healthy Sprague-Dawley rats. Pharmacol Biochem Behav. 1994;49(4):1087-91.
33. Khoury AE, Petterson U, Kallner G, Aberg-Wistedt A, Stain-Malmgren R. Calcium homeostasis in long-term lithium-treated women with bipolar affective disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(6):1063-9.
34. Rothman M. Acute hyperparathyroidism in a patient after initiation of lithium therapy. Am J Psychiatry. 1982;139:362-3.
35. Seely EW, Moore TJ, Leboff MS, Brown EM. A single dose of lithium carbonate acutely elevates intact parathyroid hormone levels in humans. Acta Endo (Buc). 1989;121:174-6.
36. Bendz H, Sjodin I, Toss G, Berglund K. Hyperparathyroidism and long-term lithium therapy - a cross-sectional study and the effect of lithium withdrawal. J Intern Med. 1996;240:357-65.
37. Fakhri H, Pathare G, Fajol A, Zhang B, Bock T, Kandolf R, et al. Pflugers Arch. 2014;66(3):467-75.
38. Zamani A, Omrani GR, Nasab MM. Lithium’s effect on bone mineral density. Bone. 2009;44:331-4.
39. Nordenstrom J, Elvius M, Bagedahl-Strindlund M, Zhao B, Torring O. Biochemical hyperparathyroidism and bone mineral status in patients treated long-term with lithium. Metabolism. 1994;43:1563-7.